Nirsevimab
Class
Antiviral agents
Subclass
Anti-RSV monoclonal antibodies
Substance name
Nirsevimab, nirsevimab‑alip
Brand names
Beyfortus®
Common formulations
Solution for injection
Dosage and administration
Pediatric patients
Prevention of RSV infection • Lower respiratory tract disease, neonates and infants born during or entering their first RSV season
Indications for use
Labeled indications
Children
Interactions
Drug(s)
Check Interactions
Reset
What did you think about this content?
Sign up for free to access the full drug resource